Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KAP for end-of-life anxiety
NCT05214417Phase 2Unknown
- Sponsor
- Ketamine Research Foundation
- Start
- May 2022
- Primary completion
- Jan 2024
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ketamine in anxiety disorder, sponsored by Ketamine Research Foundation. Status: unknown.
02
Drugs
ketamine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT05214417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05214417.